| Financial Year |
March 31 2023 |
| Monetary Funds |
3,962,875,166.77 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
459,084,126.25 |
| Advances to Suppliers |
631,731,477.05 |
| Other Receivables |
156,631,715.25 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,166,324,834.69 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
118,332,671.97 |
| Total Current Assets |
7,157,574,258.36 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
897,404,754.19 |
| Investment Properties |
-- |
| Fixed Assetes |
6,350,693,403.28 |
| Under-construction Projects |
1,902,403,033.97 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
829,852,852.02 |
| R&D expenses |
-- |
| Goodwill |
115,853,971.60 |
| Long-Term Deferred and Prepaid Expenses |
31,647,168.99 |
| Deferred Income Tax Assets |
67,790,363.99 |
| Other Non-Current Assets |
229,902,554.58 |
| Sub-Total of Non-Current Assets |
10,510,052,186.94 |
| Total Assets |
17,667,626,445.30 |
| Short-Term Loans |
2,356,289,695.84 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,646,841,142.94 |
| Accounts Payable |
1,111,525,302.12 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
46,408,987.61 |
| Taxes Payable |
104,136,652.83 |
| Interest Payable |
-- |
| Dividend Payable |
232,488.00 |
| Other payables |
128,714,840.51 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,122,803,563.73 |
| Other Current Liabilities |
13,226,633.55 |
| Sub-Total of Current Liabilities |
6,752,247,617.60 |
| Long-term Loans |
2,288,630,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
170,030,262.53 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
63,792,657.01 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
2,615,115,861.68 |
| Total Liabilities |
9,367,363,479.28 |
| Paid-In Capital(Or Share Stock) |
1,301,647,073.00 |
| Capital Surplus |
3,943,980,279.76 |
| Surplus Reserve |
282,962,373.44 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
2,613,405,047.09 |
| Minority Stockholder's Interest |
174,282,732.18 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
8,125,980,233.84 |
| Owner's Equity（Stockholder's Equity） |
8,300,262,966.02 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
17,667,626,445.30 |
